Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2010
09/29/2010CN101434601B 2-furyl-1H-benzimidazole-4-acidamide type derivative
09/29/2010CN101416973B Preparation method of novel composite anti-coccidium, antibiotic preparation
09/29/2010CN101401807B Uses of selective JAK3 restrainer VI in antiviral mediated acute lung damnification
09/29/2010CN101348486B Preparation of meropenem
09/29/2010CN101332284B Chinese traditional medicine composition for treating ulcerative colitis and its preparation method
09/29/2010CN101322692B Hydrochloric clindamycin nano granule formulation for injections
09/29/2010CN101313891B Palmatine injection and preparation method thereof
09/29/2010CN101301315B Uses of black-tail snake in preparing bait for treating lymphocyst of flatfish
09/29/2010CN101284102B Medicine for curing chronic hepatitis and hepatitis A and preparation method thereof
09/29/2010CN101269058B Spraying agent containing diclofenac acid and uses thereof
09/29/2010CN101264156B Externally-applied medicament for treating shingles
09/29/2010CN101260080B 3-(2-methyl-5-nitorimidazole)-1,2-propyl ester compound and its preparation method and use
09/29/2010CN101244068B Hemsleyadin sustained-release preparation
09/29/2010CN101239084B Ointment for treating shingles and preparation thereof
09/29/2010CN101229335B Enzyme method for preparing smilax scobinicaulis total saponin extract
09/29/2010CN101220096B Preparation and application of humanized anti-spasmotoxin monoclone antibody
09/29/2010CN101218983B Chinese medicinal herb cold tea
09/29/2010CN101152557B Preparation of aqueous extract and zymolyte of woodlousedry powder, and application of the same in medicine
09/29/2010CN101112360B Allicin fatty milk injection and preparation technics thereof
09/29/2010CN101085986B SARS coronavirus disturbance RNA and its uses
09/29/2010CN101084989B Method for preparing general flavone and total alkaloid of sophora flavescens simultaneously
09/29/2010CN101062364B Medicine for treating canine distemper disease
09/29/2010CN101032507B Bacteria resisting medicine of erythrocin nanometer-emulsion and the preparing method
09/29/2010CN101011403B Pharmaceutical composition of adefovir dipivoxil and its preparation method
09/29/2010CN101006076B Modulators of ATP-binding cassette transporters
09/28/2010US7803944 Viral polymerase inhibitors
09/28/2010US7803792 benzothiazepine compounds having a thioamide bond and a quaternary ammonium substituent, exhibiti a potent ileal bile acid transporter inhibiting activity, used for for treating hyperlipidemia or arteriosclerosis
09/28/2010US7803788 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability
09/28/2010US7803757 For treatment of urinary tract infections and inflammations, colitis, and candida infections of mucosal membranes; infant formula food containing the peptide
09/28/2010US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response
09/28/2010US7803600 inhibitors of vacuolar-type H+-ATPase; antibiotic; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16- [(1S,2R,3S)-3-[(2R,4R,5S,6R)-2,4-dihydroxy-6- isopropyl-5-methyl-2-tetrahydropyranyl]-2- hydroxy-1-methylbutyl]-8-hydroxy-3,15- dimethoxy-5,7,9,11-tetramethyl-1- oxacyclohexadeca-3,5,11,13-tetraen-2-one
09/28/2010US7803524 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates
09/28/2010US7803386 An immunogenic conjugate comprising a synthetic homopolymer of poly- gamma -glutamic acidpolypeptide covalently linked to a carrier, where the conjugate elicits an immune response against poly- gamma -glutamic acid ( gamma PGA) polypeptide; vaccine with fewer dosages; anthrax; diptheria
09/28/2010US7803378 Antigen imitating extracellular areas of membrane proteins of type III produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof
09/28/2010US7803361 Decreasing solid tumor size in a cancer patient by administering an interleukin-2 mutant with reduced vasopermeability activity compared to a wildtype form, and being Arg38Trp, wherein said wildtype form is human IL-2 mutant and the IL-2 mutant is not linked to an antibody.
09/28/2010CA2387016C Acrylamide derivatives as fab i inhibitors
09/28/2010CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity
09/28/2010CA2383257C Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
09/28/2010CA2382631C Poly(ether-thioether), poly(ether-sulfoxide) and poly(ether-sulfone) nucleic acids
09/28/2010CA2376304C Amide substituted imidazoquinolines
09/28/2010CA2371994C Enhancement of bactericidal activity of neisseria antigens with oligonucleotides containing cg motifs
09/28/2010CA2362613C Stabilized antimicrobial systems and methods of making the same
09/28/2010CA2326821C Nucleic acid encoding hyaluronan synthase and methods of use
09/28/2010CA2308201C Use of anti-fungal agents for the treatment of fungus-induced mucositis
09/27/2010CA2660622A1 Rig-i mutations and uses thereof in diagnostic and therapeutic virus-dependent immune applications
09/23/2010WO2010108190A1 Prenylated bisphosphonates as anti-tuberculosis agents
09/23/2010WO2010107742A2 Methods and compositions of treating a flaviviridae family viral infection
09/23/2010WO2010107739A2 Methods and compositions of treating a flaviviridae family viral infection
09/23/2010WO2010107454A1 Composition for photodynamic disinfection
09/23/2010WO2010107120A1 Antibody and anti-periodontal disease composition containing antibody
09/23/2010WO2010106509A2 Hcv-derived polypeptides and uses thereof
09/23/2010WO2010106355A1 Compound for the treatment of tuberculosis
09/23/2010WO2010106341A1 Compounds and biological materials and uses thereof
09/23/2010WO2010105372A1 Compositions and methods for silencing hepatitis c virus expression
09/23/2010WO2010077740A3 Novel antiviral compounds, compositions, and methods of use
09/23/2010WO2010077734A3 Novel antiviral compounds, compositions, and methods of use
09/23/2010WO2010067980A3 Histone deacetylase inhibitor that reactivates hiv-1 proviruses from latently hiv-infected cells
09/23/2010WO2010036959A3 Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
09/23/2010WO2009146885A3 Lipidated multimeric antibacterial peptides
09/23/2010WO2009142827A4 Compounds and methods for the treatment of viral infection
09/23/2010US20100240876 Replikins and methods of identifying replikin-containing sequences
09/23/2010US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells
09/23/2010US20100240770 Synthesis and use of colloidal III-V nanoparticles
09/23/2010US20100240746 Stereoisomers of tricyclodecan-9-yl-xanthogenate
09/23/2010US20100240743 Cannabinoid receptor modulator
09/23/2010US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
09/23/2010US20100240731 Lipopeptides for delivery of nucleic acids
09/23/2010US20100240727 Model for Glutamate Racemase Inhibitors and Glutamate Racemase Antibacterial Agents
09/23/2010US20100240724 Edible Film
09/23/2010US20100240704 Method of modulating stress-activated protein kinase system
09/23/2010US20100240701 Tubulysins and processes for preparing
09/23/2010US20100240698 Macrocyclic inhibitors of hepatitis c virus
09/23/2010US20100240694 Salt of naphthyridine carboxylic acid derivative
09/23/2010US20100240693 Oxime and Hydroxylamine Substituted Thiazolo [4,5-C] Ring Compounds and Methods
09/23/2010US20100240681 Valomaciclovir polymorphs
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240664 Solubilized topoisomerase poison agents
09/23/2010US20100240660 New histone deacetylases inhibitors
09/23/2010US20100240655 Bromo-phenyl substituted thiazolyl dihydropyrimidines
09/23/2010US20100240651 Water-soluble thalidomide derivatives
09/23/2010US20100240638 Organic Compounds and their uses
09/23/2010US20100240630 Compounds and therapeutic uses thereof
09/23/2010US20100240623 8-oxoadenine derivatives acting as modulators of tlr7
09/23/2010US20100240621 Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid
09/23/2010US20100240612 Prenylated Bisphosphonates as Anti-tuberculosis Agents
09/23/2010US20100240604 Protected nucleotide analogs
09/23/2010US20100240602 Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds
09/23/2010US20100240600 Anti-Norovirus Agent and Composition Containing the Same
09/23/2010US20100240592 Template-fixed peptidomimetics with antimicrobial activity
09/23/2010US20100240589 Diastereomeric peptides useful as inhibitors of membrane protein assembly
09/23/2010US20100240579 Detection of cell surface binding molecules using a phage display blocking assay
09/23/2010US20100240578 Anti-h5n1 influenza activity of the antiviral protein cyanovirin
09/23/2010US20100240577 Bacteriocins and Novel Bacterial Strains
09/23/2010US20100239690 Composition for oral cavity and skin
09/23/2010US20100239682 Colonic delivery of antimicrobial agents
09/23/2010US20100239657 Composite for liver-specific delivery and release of therapeutic nucleic acids or drugs
09/23/2010US20100239641 Warming vapor pad
09/23/2010US20100239633 Immunoglobulin constant region fc receptor binding agents
09/23/2010US20100239617 Modified rsv f proteins and methods of their use
09/23/2010US20100239613 Attenuated ehrlichiosis vaccine
1 ... 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 ... 1798